» Articles » PMID: 32176646

Inflammation in Traumatic Brain Injury

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2020 Mar 17
PMID 32176646
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

There is an increasing evidence that inflammation contributes to clinical and functional outcomes in traumatic brain injury (TBI). Many successful target-engaging, lesion-reducing, symptom-alleviating, and function-improving interventions in animal models of TBI have failed to show efficacy in clinical trials. Timing and immunological context are paramount for the direction, quality, and intensity of immune responses to TBI and the resulting neuroanatomical, clinical, and functional course. We present components of the immune system implicated in TBI, potential immune targets, and target-engaging interventions. The main objective of our article is to point toward modifiable molecular and cellular mechanisms that may modify the outcomes in TBI, and contribute to increasing the translational value of interventions that have been identified in animal models of TBI.

Citing Articles

Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies.

Mallick R, Basak S, Chowdhury P, Bhowmik P, Das R, Banerjee A Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861166 PMC: 11769149. DOI: 10.3390/ph18010104.


Severity of Repetitive Mild Traumatic Brain Injury Depends on Microglial Heme Oxygenase-1 and Carbon Monoxide.

Kaiser S, Fritsch A, Jakob L, Schallner N Eur J Neurosci. 2025; 61(2):e16666.

PMID: 39844588 PMC: 11755003. DOI: 10.1111/ejn.16666.


Agathisflavone Modulates Reactive Gliosis After Trauma and Increases the Neuroblast Population at the Subventricular Zone.

Castro E Silva J, Pieropan F, Rivera A, Butt A, Costa S Nutrients. 2024; 16(23).

PMID: 39683446 PMC: 11642973. DOI: 10.3390/nu16234053.


The Role of Neuroinflammation in Shaping Neuroplasticity and Recovery Outcomes Following Traumatic Brain Injury: A Systematic Review.

Calderone A, Latella D, Cardile D, Gangemi A, Corallo F, Rifici C Int J Mol Sci. 2024; 25(21).

PMID: 39519259 PMC: 11546226. DOI: 10.3390/ijms252111708.


Inflammation and olfactory loss are associated with at least 139 medical conditions.

Leon M, Troscianko E, Woo C Front Mol Neurosci. 2024; 17:1455418.

PMID: 39464255 PMC: 11502474. DOI: 10.3389/fnmol.2024.1455418.


References
1.
Logsdon A, Erickson M, Rhea E, Salameh T, Banks W . Gut reactions: How the blood-brain barrier connects the microbiome and the brain. Exp Biol Med (Maywood). 2017; 243(2):159-165. PMC: 5788145. DOI: 10.1177/1535370217743766. View

2.
Klune J, Dhupar R, Cardinal J, Billiar T, Tsung A . HMGB1: endogenous danger signaling. Mol Med. 2008; 14(7-8):476-84. PMC: 2323334. DOI: 10.2119/2008-00034.Klune. View

3.
Smith C, Gentleman S, Leclercq P, Murray L, Griffin W, Graham D . The neuroinflammatory response in humans after traumatic brain injury. Neuropathol Appl Neurobiol. 2012; 39(6):654-66. PMC: 3833642. DOI: 10.1111/nan.12008. View

4.
de Rivero Vaccari J, Lotocki G, Alonso O, Bramlett H, Dietrich W, Keane R . Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J Cereb Blood Flow Metab. 2009; 29(7):1251-61. PMC: 2846547. DOI: 10.1038/jcbfm.2009.46. View

5.
Turkoglu O, Eroglu H, Okutan O, Gurcan O, Bodur E, Sargon M . Atorvastatin efficiency after traumatic brain injury in rats. Surg Neurol. 2008; 72(2):146-52. DOI: 10.1016/j.surneu.2008.07.004. View